Cellectis (CLLS) Tops Q4 EPS by 58c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.02), $0.58 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $17.32 million versus the consensus estimate of $18.58 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• BMO Capital Upgrades Casey's General Stores (CASY) to Outperform, 'Opportunity Knocks'
• Genesco names Jonathan Collins as CFO, effective August 2026
• TD Cowen Upgrades PBF Energy (PBF) to Hold